Evia Bio, Inc.

SEC filing

Biotechnology · Minneapolis, MN

Form D on EDGAR

Amount raised$5.5Msold at filing

Total offering$5.5M

Investors in the raise19count reported to the SEC

FiledSep 28, 2026first sale Sep 14, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Marc CentrellaDirector

Allison HubelDirector

Scott FisherDirector

Jeffrey AllenExecutive Officer, Director

Troy WichtermanDirector

Executive officers, directors and promoters as listed on the Form D.